Washington, DC
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)International Society for Pharmacoepidemiology, founded in 1989, is a community nonprofit that reported $2.4M in total revenue in fiscal year 2022. Revenue surged 188% from the prior year, signaling strong growth momentum. Expenses of $3.0M exceeded revenue, resulting in a 24% operating deficit.
Development and management of scientific forums: 1) convene an annual scientific forum (international conference on pharmacoepidemiology & therapeutic risk management - ICPE) where members of the...
Development and management of scientific forums: 1) convene an annual scientific forum (international conference on pharmacoepidemiology & therapeutic risk management - ICPE) where members of the discipline meet to network, present results of methodological investigations and studies in progress, discuss public health policy issues concerning pharmacoepidemiology, therapeutic risk management, and other related fields. 2) Convene regular regional and local meetings on scientific and public policy issues, which currently includes a mid-year conference in conjunction with meetings of the board of directors and scientific program committee; and an annual Asian conference (ACPE) partnered with local scientific and professional societies.
The Societys communications program delivers: 1) a website with significant resources on the expanding science and practice of pharmacoepidemiology, and presents ISPEs goals and objectives to...
The Societys communications program delivers: 1) a website with significant resources on the expanding science and practice of pharmacoepidemiology, and presents ISPEs goals and objectives to current/prospective members, and the general public; and 2) regular email updates to members on developments in pharmacoepidemiology, or about ISPE.
Publications: 1) The Society provides a members-only subscription to Pharmacoepidemiology and Drug Safety, a leading scientific journal publishing definitive, peer-reviewed papers on the science and...
Publications: 1) The Society provides a members-only subscription to Pharmacoepidemiology and Drug Safety, a leading scientific journal publishing definitive, peer-reviewed papers on the science and practice of pharmacoepidemiology; and 2) a Manuscript Initiative, which funds the development of resource documents focused on pharmacoepidemiology, pharmacovigilance, drug utilization research, outcomes research, comparative effectiveness research, and therapeutic risk management.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2022 | 2021 | Change | |
|---|---|---|---|
| Revenue | $2,385,393 | $827,522 | +1.9% |
| Expenses | $2,953,759 | $891,957 | +2.3% |
| Net Income | $-568,366 | $-64,435 | +7.8% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| Andrea Margulis | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Hongbo Yuan | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Stanley Edlavitch | Executive Director Emeritus | 1.00 |
Director
|
$0 | $0 | $0 |
| Ursula Kirchmayer | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Daniel Prieto-Alhambra | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Yoshiaki Uyama | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Jennifer Lund | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Stine Hasling Mogensen | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Tomoko Kobayashi | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Mette Norgaard | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Jessica Franklin | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Gillian Caughey | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Shirley Wang | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Montserrat Soriano Gabarro | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Jeremy Rassen | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Efe Eworuke | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Lisa Pont | President-Elect | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| Vincent Lo Re | Immediate Past President | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| Caitlin Knox | VP Finance-Elect | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| Tobias Gerhard | President | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| James Vrac | Executive Secretary | 20.00 |
Officer
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | No data | No data | No data | No data |
| 2024 | No data | No data | No data | No data |
| 2023 | $2,385,393 | $2,953,759 | $3,943,001 | $-568,366 |
| 2022 | $827,522 | $891,957 | $4,224,312 | $-64,435 |
| 2021 | $911,170 | $943,126 | $3,912,869 | $-31,956 |
| 2020 | $2,374,699 | $1,959,645 | $3,709,080 | $415,054 |
| 2019 | $2,032,537 | $1,920,082 | $4,057,343 | $112,455 |
| 2018 | $1,749,841 | $1,834,180 | $3,697,146 | $-84,339 |
Compare International Society for Pharmacoepidemiology with other nonprofits in District of Columbia and across the country.